Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C during the anhepatic phase of liver transplantation for prevention of reperfusion syndrome
2020-000123-39Phase 2Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ascorbic acid in ischemia-reperfusion injury (IRI) (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoint: Incidence of reperfusion syndrome. Started Feb 2020; status: active.
02
Drugs
ascorbic acid
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on 2020-000123-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000123-39.